Analysis of ANGPTL in diabetes with dyslipidemia

Analysis of ANGPTL in diabetes with dyslipidemia - Analysis of ANGPTL

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000034317

Enrollment

100

Registered

2018-09-28

Start date

2018-09-26

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)patient taking oral lipid-related drugs or having dyslipidemia 2) Patients who are on diet therapy, exercise therapy only or oral hypoglycemic drug or insulin treatment. 3) Patients who can obtain written consent for participation in this study

Exclusion criteria

Exclusion criteria: Patients with severe ketosis, diabetic coma or precoma, severe infections, patients with severe trauma.

Design outcomes

Primary

Measure	Time frame
Correlation between diabetes-related numerical values (insulin resistance, HbA1c) and ANGPTLs	—

Secondary

Measure	Time frame
1) Arteriosclerosis: Correlation with carotid artery echo, macroangiopathy, presence of minimum vascular disease, etc. with ANGPTL 2) Obesity: Correlation between BMI, visceral fat area and ANGPTL 3) Lipid-related: Correlation between Apo protein, fatty acid fraction, LPL, etc. and ANGPTL 4) Change in ANGPTL due to improvement in blood glucose / lipid metabolism	—

Countries

Japan

Contacts

Public ContactMarina Harada

Yokohama City University Medical Center Department of Endocrinology and Diabetes

onyogora@yokohama-cu.ac.jp045-261-5656

Outcome results